Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,096 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysis.
Brandt L, Ritter K, Schneider-Thoma J, Siafis S, Montag C, Ayrilmaz H, Bermpohl F, Hasan A, Heinz A, Leucht S, Gutwinski S, Stuke H. Brandt L, et al. Among authors: hasan a. Lancet Psychiatry. 2023 Mar;10(3):184-196. doi: 10.1016/S2215-0366(23)00008-1. Lancet Psychiatry. 2023. PMID: 36804071 Clinical Trial.
Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
Hasan A, Wobrock T, Grefkes C, Labusga M, Levold K, Schneider-Axmann T, Falkai P, Müller H, Klosterkötter J, Bechdolf A. Hasan A, et al. Biol Psychiatry. 2012 Nov 1;72(9):744-51. doi: 10.1016/j.biopsych.2012.03.005. Epub 2012 Apr 12. Biol Psychiatry. 2012. PMID: 22502988
Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model.
Böge K, Karnouk C, Hahn E, Schneider F, Habel U, Banaschewski T, Meyer-Lindenberg A, Salize HJ, Kamp-Becker I, Padberg F, Hasan A, Falkai P, Rapp MA, Plener PL, Stamm T, Elnahrawy N, Lieb K, Heinz A, Bajbouj M. Böge K, et al. Among authors: hasan a. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):95-106. doi: 10.1007/s00406-019-00991-5. Epub 2019 Feb 22. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 30796528
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J. Schmidt-Kraepelin C, et al. Among authors: hasan a. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):83-94. doi: 10.1007/s00406-019-01063-4. Epub 2019 Sep 5. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31486890
Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin.
Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K. Pollak TA, et al. Among authors: hasan a. Lancet Psychiatry. 2020 Jan;7(1):93-108. doi: 10.1016/S2215-0366(19)30290-1. Epub 2019 Oct 24. Lancet Psychiatry. 2020. PMID: 31669058 Review.
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
Huhn M, Leucht C, Rothe P, Dold M, Heres S, Bornschein S, Schneider-Axmann T, Hasan A, Leucht S. Huhn M, et al. Among authors: hasan a. Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):293-302. doi: 10.1007/s00406-020-01109-y. Epub 2020 Feb 15. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 32062728 Free PMC article. Clinical Trial.
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
Hasan A, Roeh A, Leucht S, Langguth B, Hansbauer M, Oviedo-Salcedo T, Kirchner SK, Papazova I, Löhrs L, Wagner E, Maurus I, Strube W, Rossner MJ, Wehr MC, Bauer I, Heres S, Leucht C, Kreuzer PM, Zimmermann S, Schneider-Axmann T, Görlitz T, Karch S, Egert-Schwender S, Schossow B, Rothe P, Falkai P. Hasan A, et al. Contemp Clin Trials Commun. 2020 Jan 28;17:100537. doi: 10.1016/j.conctc.2020.100537. eCollection 2020 Mar. Contemp Clin Trials Commun. 2020. PMID: 32072071 Free PMC article.
2,096 results